A Novel, No Wash Screening Assay to Simultaneously Measure Binding to Target and Control Antigens on Mammalian Cell Surfaces
25 September 2012

A key process in the discovery of new antibody therapeutics lies in the screening of hybridoma and phage display libraries for candidates that bind specifically the target antigen of interest, and not to unrelated antigens. This scientific poster, presented at ELRIG Drug Discovery 2012, describes how the mix-and-measure hybridoma screening assay from IntelliCyt can be used to optimize the antibody screening process. The assay enables users to simultaneously test the binding of antibodies to both target and control antigens on the surface of cells.

Popular tags in SelectScience

Buying guides

Write a Review

Join the Global SelectScience Community Today! It’s FREE!

Helping you make informed decisions about the latest lab products and technologies:

  • Be the first to learn about new technologies
  • 10,000+ trusted product reviews from your peers
  • Compare 500,000 products and manufacturers
  • Get exclusive buying tips from experts
  • Find solutions fast: 10,000+ Application Notes, Webinars and Videos

Connect with 250,000 scientists... All in one place!

Become a member today!